UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

January 3, 2020

ORDER GRANTING CONFIDENTIAL TREATMENT

UNDER THE SECURITIES EXCHANGE ACT OF 1934

Tesla, Inc.

File No. 1-34756 - CF#35364

_____________________

Tesla, Inc. submitted an application under Rule 24b-2 requesting an extension of a previous grant of confidential treatment for information it excluded from the Exhibits to a Form 10-Q filed on August 4, 2017.

Based on representations by Tesla, Inc. that this information qualifies as confidential commercial or financial information under the Freedom of Information Act, 5 U.S.C. 552(b)(4), the Division of Corporation Finance has determined not to publicly disclose it. Accordingly, excluded information from the following exhibits will not be released to the public for the time period specified:

Exhibit 10.4

through December 31, 2020

Exhibit 10.5

through December 31, 2020

Exhibit 10.7

through December 31, 2020

Exhibit 10.8

through December 31, 2020

For the Commission, by the Division of Corporation Finance, pursuant to delegated authority:

Vanessa A. Countryman

Secretary

Attachments

  • Original document
  • Permalink

Disclaimer

Tesla Inc. published this content on 03 January 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 03 January 2020 14:12:05 UTC